- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Napp was accused of off-licence renoprotection claims and missing renal dosing/adult-only info in an Invokana webcast ad. Panel found the page linked…
Sanofi’s Toujeo DoubleStar slide deck claimed “fewer prescriptions”, a claim it had already agreed was unsubstantiated. PMCPA ruled it misleading and found…
Complaint about Chiesi’s respiratory website: alleged public advertising of POMs, weak HCP gating, vague “carer” wording, out-of-date videos and disparaging Nexthaler comments.…
A HCP alleged GSK repeatedly breached the same Code clause and therefore breached an earlier undertaking. The Panel ruled a breach of…
A senior AstraZeneca global employee posted a LinkedIn update linking to a vaccine efficacy press release pre-authorisation. UK employees ‘liked’ it, amplifying…
LEO’s Protopic HCP webpage breached the Code for an image implying no need for sun precautions and for a maintenance-therapy flare-delay graph…
Employee complaint about field-force instructions during Covid. Panel found a rep’s hospital-access email and a manager’s team-wide response fell below standards, breaching…
Anonymous HCP alleged GW promoted medicines/pipeline to patients/public at a ketogenic diet symposium. Panel found no evidence of public exposure or medicine…
A health professional said Sixmo materials depicting patients as puppets were derogatory and ignored market research feedback. PMCPA found the campaign unlikely…
PMCPA found Saxenda HCP leavepiece omitted the 12‑week 5% weight-loss stopping rule from the indication and main body, and PI was inconsistent…
Gilead’s HIV.eu HCP site briefly remained accessible after “visit patient site” failed. Panel found promotional HCP content likely visible to the public…
Anonymous HCP said Ocrevus website claim ‘generally well tolerated’ was misleading given serious/fatal AEs in SPC. Panel found the claim sufficiently qualified…
Complaint alleged disguised promotion of MSD’s chickenpox vaccine via Politico London Playbook and stopthespots.co.uk. Panel ruled no breach (Clauses 3.6, 5.1) as…
PMCPA found a Clause 5.1 breach after a UK-based AstraZeneca Global employee ‘liked’ a Reuters/LinkedIn post about Evusheld before UK authorisation. Other…
Complaint alleged Trulicity email claims were unclear on comparator, patient details and statistical significance, and that a secondary endpoint (weight) was presented…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.